Literature DB >> 25201009

Employing Bayesian approach to the intermediate risk categories of the Bethesda thyroid cytopathology reporting system: can FDG PET/CT find a strong enough evidence-base to be practised clinically as an adjunct?

Sandip Basu1.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25201009     DOI： 10.1007/s00259-014-2908-2

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  6 in total

Review 1.  The Bethesda System For Reporting Thyroid Cytopathology.

Authors:  Edmund S Cibas; Syed Z Ali
Journal:  Am J Clin Pathol       Date:  2009-11       Impact factor: 2.493

2.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

Authors:  David S Cooper; Gerard M Doherty; Bryan R Haugen; Bryan R Hauger; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Furio Pacini; Martin Schlumberger; Steven I Sherman; David L Steward; R Michael Tuttle
Journal:  Thyroid       Date:  2009-11       Impact factor: 6.568

Review 3.  The Proportion of Malignancy in Incidental Thyroid Lesions on 18-FDG PET Study: A Systematic Review and Meta-analysis.

Authors:  Smriti Nayan; Jayant Ramakrishna; Michael K Gupta
Journal:  Otolaryngol Head Neck Surg       Date:  2014-04-23       Impact factor: 3.497

4.  Differentiated thyroid cancer incidentally detected by ¹⁸F-FDG PET/CT: patient's future in a hot-spot?

Authors:  Silvia Morbelli; Marcello Bagnasco
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-08       Impact factor: 9.236

5.  Unfolding the role of PET FDG scan in the management of thyroid incidentaloma in cancer patients.

Authors:  Haim Gavriel; Adrian Tang; Ephraim Eviatar; Sor Way Chan
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-06       Impact factor: 2.503

6.  ¹⁸F-FDG uptake as a prognostic variable in primary differentiated thyroid cancer incidentally detected by PET/CT: a multicentre study.

Authors:  Arnoldo Piccardo; Matteo Puntoni; Francesco Bertagna; Giorgio Treglia; Luca Foppiani; Federico Arecco; Raffaele Giubbini; Mehrdad Naseri; Angelina Cistaro; Manlio Cabria; Francesca Bardesono; Luca Ceriani; Fabio Orlandi; Luca Giovanella
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-04-30       Impact factor: 9.236
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.